TrialBritish journal of cancer2015

Clinical and genomic analysis of a randomised phase II study evaluating anastrozole and fulvestrant in postmenopausal patients treated for large operable or locally advanced hormone-receptor-positive breast cancer.

Nathalie Quenel-Tueux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.